Beaton Management Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.41M Sell
5,886
-25
-0.4% -$25.3K 2.41% 10
2025
Q4
$6.35M Sell
5,911
-20
-0.3% -$19.1K 2.8% 5
2025
Q3
$4.53M Buy
5,931
+20
+0.3% +$14.9K 2.06% 11
2025
Q2
$4.61M Hold
5,911
2.25% 10
2025
Q1
$4.88M Hold
5,911
2.53% 10
2024
Q4
$4.56M Buy
5,911
+164
+3% +$136K 2.3% 10
2024
Q3
$5.09M Buy
5,747
+15
+0.3% +$13.5K 2.58% 8
2024
Q2
$5.19M Buy
5,732
+5
+0.1% +$4K 2.79% 5
2024
Q1
$4.46M Buy
5,727
+27
+0.5% +$19.2K 2.43% 11
2023
Q4
$3.32M Buy
+5,700
New +$3.33M 1.99% 14
2022
Q2
Sell
-4,858
Closed -$1.39M 136
2022
Q1
$1.39M Hold
4,858
0.86% 40
2021
Q4
$1.34M Sell
4,858
-85
-2% -$21.5K 0.8% 40
2021
Q3
$1.14M Hold
4,943
0.76% 41
2021
Q2
$1.14M Buy
4,943
+450
+10% +$90.4K 0.72% 47
2021
Q1
$839K Hold
4,493
0.58% 54
2020
Q4
$759K Hold
4,493
0.56% 58
2020
Q3
$665K Hold
4,493
0.55% 60
2020
Q2
$738K Hold
4,493
0.66% 53
2020
Q1
$623K Hold
4,493
0.62% 57
2019
Q4
$591K Hold
4,493
0.46% 62
2019
Q3
$502K Buy
4,493
+650
+17% +$72.4K 0.41% 71
2019
Q2
$426K Hold
3,843
0.35% 77
2019
Q1
$499K Hold
3,843
0.43% 70
2018
Q4
$445K Sell
3,843
-100
-3% -$11.2K 0.44% 70
2018
Q3
$423K Buy
3,943
+185
+5% +$18.5K 0.35% 80
2018
Q2
$321K Hold
3,758
0.29% 92
2018
Q1
$291K Hold
3,758
0.27% 96
2017
Q4
$317K Hold
3,758
0.29% 91
2017
Q3
$321K Sell
3,758
-100
-3% -$8.2K 0.3% 86
2017
Q2
$318K Buy
+3,858
New +$315K 0.32% 84

Other funds holding LLY

Beaton Management Company's LLY Position: Q1 2026 in Review

Beaton Management Company reduced its Eli Lilly (LLY) stake by 0.42% in Q1 2026, selling an estimated $25.3K and leaving 5,886 shares worth $5.41M. The position accounts for 2.41% of the portfolio, ranked #10.

Beaton Management Company first reported a position in LLY in Q2 2017 and has held it in 30 quarters since. The position peaked at $6.35M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Beaton Management Company held 5,886 shares of Eli Lilly worth $5.41M as of Q1 2026.
  • Beaton Management Company sold 25 Eli Lilly shares in Q1 2026, an estimated $25.3K.
  • Eli Lilly made up 2.41% of Beaton Management Company's portfolio in Q1 2026, its #10 holding.
  • Beaton Management Company first reported a position in Eli Lilly in Q2 2017 and has held it in 30 quarters since.
  • Beaton Management Company's Eli Lilly position peaked at $6.35M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Beaton Management Company's 13F filing for Q1 2026, filed 12 May 2026.